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Multiple disciplines are involved in the management of diabetic foot disease and a common 
vocabulary is essential for clear communication. Based on the systematic reviews of the literature 
that form the basis of the International Working Group on the Diabetic Foot (IWGDF) Guidelines, the 
IWGDF has developed a set of definitions and criteria for diabetic foot disease. This document 
describes these definitions and criteria. We suggest these definitions be used consistently in both 







Multiple disciplines are involved in the management of diabetic foot disease, and interdisciplinary 
treatment is the cornerstone of its management and prevention. With all these disciplines involved, a 
common vocabulary is essential for clear clinical communication purposes. For research purposes, 
clear and unequivocal definitions are imperative for study methodology to be comparable between 
studies and repeatable in different settings.  
 
Since its inception in 1999, the International Working Group on the Diabetic Foot (IWGDF) has 
created a set of core definitions related to diabetic foot disease, its diagnoses and interventions. 
These definitions were published online or as addendum to the systematic reviews (1). Further, the 
“Reporting standards of studies and papers on the prevention and management of foot ulcers in 
diabetes” (2) also noted that these definitions should be used, to facilitate uniform reporting. 
 
In this paper, we provide an update of all definitions and criteria for diabetic foot disease based on 
the systematic reviews of the literature that form the basis of the 2019 IWGDF Guidelines (3-9). 
Where possible, we have retained the definitions from previous versions (1), to facilitate consistent 
comparison with older studies. We have only made changes when the evidence necessitated updates 
of older definitions. When no previous definition was available, we developed a definition based on 
the literature findings. To indicate the changes in this list of definitions and criteria, we have denoted 
new definitions with an asterisk (*) and updated definitions with an obelisk (†).  
 
This paper is limited to general definitions and criteria for diabetic foot disease. Further specific 
definitions can also be found in the glossary of 2019 IWGDF guidelines, such as in the prevention and 
offloading guidelines (4,5). We do not provide definitions on diabetes or on other (chronic) diseases 
unless it is specifically relevant to the topic (e.g. for peripheral artery disease-related definitions). 
Finally, it should be noted that the definitions in this paper are limited by being primarily based on 
expert opinion, and no formal methodology has been used in this definition development.  
 
We suggest the definitions in this paper be used consistently in both clinical practice and research, to 
facilitate clear communication between professionals. 
 
 
DIABETIC FOOT DISEASE RELATED DEFINITIONS 
 
Diabetic foot: Infection, ulceration or destruction of tissues of the foot of a person with currently or 
previously diagnosed diabetes mellitus, usually accompanied by neuropathy and/or peripheral artery 
disease in the lower extremity.  
Diabetic neuropathy: The presence of symptoms or signs of nerve dysfunction in a person with (a 
history of) diabetes mellitus, after exclusion of other causes. 
Loss of protective sensation: A sign of diabetic neuropathy, characterised by an inability to sense 
light pressure e.g. as applied with a 10 gram Semmes-Weinstein monofilament. 
Neuro-osteoarthropathy (Charcot-foot): Non-infectious destruction of bone and joint(s) associated 
with neuropathy, which, in the acute phase, is associated with signs of inflammation. 
 
Person at risk*: A person with diabetes who is at risk of developing a foot ulcer by minimally having 




Forefoot*: The anterior (distal) part of the foot, that is composed of the metatarsal bones, the 
phalanges and associated soft tissue structures. 
 
Midfoot*: The part of the foot that is composed of the cuboid, navicular, and cuneiform bones, and 
associated soft tissue structures. 
 
Rearfoot or hindfoot*: The posterior (proximal) part of the foot that is composed of the talus and 
calcaneus, and associated soft tissue structures. 
 
Plantar foot surface*: The underside or weight-bearing surface of the foot. 
 
Non-plantar foot surface*: All other surfaces of the foot not defined as a plantar foot surface. 
 
Dorsal foot surface*: The upper side of the foot, opposite of the plantar foot surface. 
 
Foot deformity: Alterations or deviations from normal shape or size of the foot, such as hammer 
toes, mallet toes, claw toes, hallux valgus, prominent metatarsal heads, pes cavus, pes planus, pes 
equinus, or results of Charcot neuro-osteoarthropathy, trauma, amputations, other foot surgery or 
other causes. 
Limited joint mobility: Reduced mobility of the joints of the foot, including the ankle, caused by 
changes in joints and associated soft tissues.  
Callus: Hyperkeratosis caused by excessive mechanical loading. 
 
Plantar pressure*: The distribution of forces over a given plantar foot surface, mathematically 
defined as ‘force divided by the contact area’. Often expressed as peak pressure or pressure-time 
integral.  
 
FOOT ULCER RELATED DEFINITIONS 
Foot ulcer†: A break of the skin of the foot that involves as a minimum the epidermis and part of the 
dermis. 
 
Diabetic foot ulcer*: Foot ulcer in person with currently or previously diagnosed diabetes mellitus, 
and usually accompanied by neuropathy and/or peripheral artery disease in the lower extremity. 
 
Healed foot ulcer: Intact skin, meaning complete epithelialization without any drainage of a previous 
foot ulcer site. 
 
Foot in remission*: Intact skin, and absence of infection, of the complete foot after healing of any 
foot ulcer(s). 
 
Pre-ulcerative lesion*: Foot lesion that has a high risk of developing into a foot ulcer, such as intra- 
or subcutaneous haemorrhage, blister, or skin fissure not penetrating into the dermis, in a person at 
risk. 
 
Foot lesion: Any abnormality associated with damage to the skin, nails or deep tissues of the foot. 
 
First-ever foot ulcer†: A foot ulcer occurring in a person who has never before had a foot ulcer.  
 
Recurrent foot ulcer: New foot ulcer in a person who has a history of foot ulceration, irrespective of 
location and time, since previous foot ulcer. 
 
Superficial foot ulcer†: A foot ulcer not penetrating any structure deeper than the dermis. 
 
Deep foot ulcer†: A foot ulcer penetrating below the dermis into subcutaneous structures, such as 
fascia, muscle, tendon or bone. 
 
Ulcer-free survival days*: Days that a person is alive and without a foot ulcer. 
 
 
PERIPHERAL ARTERY DISEASE RELATED DEFINITIONS 
 
Peripheral artery disease (PAD): Obstructive atherosclerotic vascular disease with clinical symptoms, 
signs or abnormalities on non-invasive or invasive vascular assessment, resulting in disturbed or 
impaired circulation in one or more extremities 
 
Claudication: Pain in the thigh or calf that occurs during walking and is relieved by rest, and is caused 
by peripheral artery  disease.  
 
Rest pain: Severe and persistent pain localized in the foot caused by peripheral artery disease that 
may be relieved by putting the foot in a dependent position. 
 
Angioplasty†: An endovascular technique used to re-establish the patency of an artery by 
percutaneous transluminal or subintimal procedures. 
 




INFECTION RELATED DEFINITIONS 
 
Infection: A pathological state caused by invasion and multiplication of microorganisms in host 
tissues accompanied by tissue destruction and/or a host inflammatory response. 
 
Superficial infection: An infection of the skin not extending to any structure deeper than the dermis. 
 
Deep infection: An infection that extends deeper than the dermis, that may include abscess, septic 
arthritis, osteomyelitis, septic tenosynovitis or necrotising fasciitis. 
 
Erysipelas*: An infection of the upper part of the skin (epidermis and dermis, not hypodermis) 
manifested by one or more of the following: induration, erythema, warmth, pain or tenderness. 
 
Cellulitis†: An infection of the skin (epidermis and dermis and hypodermis [subcutaneous fat and 
connective tissue]) manifested by one or more of the following: induration, erythema, warmth, pain 
or tenderness. 
 
Septic arthritis*: an infection of the joint and joint capsule. 
 
Osteomyelitis: An infection of the bone, with involvement of the bone marrow. 
 
Pathogen*: A microorganism that is considered to be causing an infection, as opposed to colonizing 
or contaminating tissue. 
 
 
AMPUTATION RELATED DEFINITIONS 
Amputation: Resection of a segment of a limb through a bone or through a joint. 
 
Major amputation: Any resection proximal to the ankle. 
 
Major amputation levels: 
TT = transtibial amputation: amputation through the tibia and fibula (frequently referred to as 'below 
knee amputation') 
KD = knee disarticulation: amputation through the knee (frequently referred to as 'through knee 
amputation') 
TF = transfemoral amputation: amputation through the femur (frequently referred to as 'above knee 
amputation') 
 
Minor amputation: Any resection through or distal to the ankle. 
 
Minor amputation levels:  
1. toe amputation 
2. metatarsal-phalangeal disarticulation 
3. distal transmetatarsal amputation 
4. proximal transmetatarsal amputation 
5. tarso-metatarsal disarticulation 
6. midtarsal disarticulation 





Interdisciplinary (or multidisciplinary) clinical team*: A grouping of people from relevant clinical 
disciplines, whose interactions are guided by specific team functions and processes to achieve team- 
and person-defined favourable outcomes. (Based on: (10)). 
 
Necrosis: Devitalised (dead) tissue. 
 
Gangrene†: A condition that occurs when body tissue dies because of insufficient blood supply, 
infection or injury. Without infection this generally results in dry and black tissue, frequently called 
dry gangrene; when the tissue is infected, with accompanying putrefaction and surrounding cellulitis, 
it is often called wet gangrene. 
 
Oedema of the lower limb: Swelling of the leg or foot caused by increased interstitial fluid. 
 
Erythema†: A pink or red discoloration that blanches to some degree on compression, caused by 
increased blood flow to the involved tissue. 
 
Debridement†: The removal of callus or dead tissue that can be surgical (“sharp”) or non-surgical 
(e.g. abrasion, chemical). 
 
Offloading: The relief of mechanical stress (pressure) from a specific region of the foot. 
 
Offloading intervention: Any intervention undertaken with the intention of relieving mechanical 
stress (pressure) from a specific region of the foot (includes surgical offloading techniques, offloading 




CRITERIA FOR DIABETIC FOOT DISEASE 
 
Diabetic foot ulcer risk: Criteria for foot ulcer risk in people with diabetes are defined in the IWGDF 
Risk Stratification system; please see the IWGDF Prevention Guideline for these criteria and their 
details (4). 
 
Peripheral artery disease: Criteria for diagnosing peripheral artery disease in people with diabetes 
and a foot ulcer are defined in the PAD Guideline; please see the IWGDF PAD Guideline for these 
criteria and their details (6). 
 
Foot infection: Criteria for diagnosing foot infection in people with diabetes are defined in the 
IWGDF/IDSA foot infection classification system; please see the IWGDF Infection Guideline for these 
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